BioCardia, Inc. Public Float
BioCardia, Inc. (BCDA) had Public Float of $9.70 million as of 2025-06-30, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-24
- 2025-06-30: Entity Public Float $9.70M.
- 2024-06-28: Entity Public Float $5.60M.
- 2023-06-30: Entity Public Float $48.00M.
- 2022-06-30: Entity Public Float $19.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $9.70M 10-K · filed 2026-03-24 |
| 2024-06-28 | $5.60M 10-K · filed 2025-03-26 |
| 2023-06-30 | $48.00M 10-K · filed 2024-03-27 |
| 2022-06-30 | $19.80M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $51.80M 10-K · filed 2022-03-29 |
| 2020-06-30 | $20.60M 10-K · filed 2021-03-30 |
| 2019-06-30 | $23.23M 10-K · filed 2020-04-09 |
| 2018-06-30 | $27.40M 10-K · filed 2019-04-02 |
| 2017-06-30 | $147.67M 10-K · filed 2018-03-16 |
| 2016-06-30 | $11.51M 10-K · filed 2017-03-30 |
| 2015-06-30 | $12.70M 10-K · filed 2016-03-25 |
| 2014-06-30 | $9.82M 10-K · filed 2015-03-24 |
| 2013-06-30 | $7.00M 10-K · filed 2014-03-24 |
| 2012-06-30 | $6.20M 10-K · filed 2013-03-22 |
| 2011-06-30 | $7.08M 10-K · filed 2012-03-29 |
| 2010-06-30 | $45.94M 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |